首页 | 本学科首页   官方微博 | 高级检索  
检索        

临床药师参与1例浅黄假单胞菌血流感染合并终末期肾病患者的药学实践
引用本文:刘启迪,朱裕林,师佩兰,孟祥辉,刘义杰,肖洪敏.临床药师参与1例浅黄假单胞菌血流感染合并终末期肾病患者的药学实践[J].中国现代应用药学,2019,36(15):1951-1954.
作者姓名:刘启迪  朱裕林  师佩兰  孟祥辉  刘义杰  肖洪敏
作者单位:临泉县人民医院, 药剂科, 安徽阜阳 236400,蚌埠医学院第一附属医院药剂科, 安徽 蚌埠 233000,蚌埠医学院第一附属医院药剂科, 安徽 蚌埠 233000,临泉县人民医院, 肾内风湿免疫科, 安徽阜阳 236400,临泉县人民医院, 药剂科, 安徽阜阳 236400,临泉县人民医院, 药剂科, 安徽阜阳 236400
摘    要:目的 探讨临床药师在抗感染药物治疗中发挥的作用。方法 临床药师通过参与1例浅黄假单胞菌血流感染合并终末期肾病患者的药学实践,探讨如何为感染合并肾病患者制定合理的抗感染治疗方案。结果 临床药师积极参与药物治疗,依据指南评价抗感染治疗方案,根据药敏结果和患者既往史,给予合理的抗感染治疗方案的修改建议,最终感染得到有效控制。结论 感染严重影响生活质量。临床药师协助医师选择适宜的抗菌药物、用法用量、正确联合用药,关注药物不良反应,制定个体化给药方案,保障感染合并肾病患者有效并合理应用抗菌药物。

关 键 词:浅黄假单胞菌  血流感染  肾功能衰竭  临床药师  药学实践
收稿时间:2018/9/26 0:00:00

Clinical Pharmacists Involved in A Case of Pharmaceutical Practice of Chryseomonas Luteola Bloodstream Infection with End Stage Renal Disease
LIU Qidi,ZHU Yulin,SHI Peilan,MENG Xianghui,LIU Yijie and XIAO Hongmin.Clinical Pharmacists Involved in A Case of Pharmaceutical Practice of Chryseomonas Luteola Bloodstream Infection with End Stage Renal Disease[J].The Chinese Journal of Modern Applied Pharmacy,2019,36(15):1951-1954.
Authors:LIU Qidi  ZHU Yulin  SHI Peilan  MENG Xianghui  LIU Yijie and XIAO Hongmin
Institution:Linquan County People''s Hospital, Department of Pharmacy, Fuyang 236400, China,Department of Pharmacy, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China,Department of Pharmacy, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China,Linquan County People''s Hospital, Department of Rheumatology and Immunology, Fuyang 236400, China,Linquan County People''s Hospital, Department of Pharmacy, Fuyang 236400, China and Linquan County People''s Hospital, Department of Pharmacy, Fuyang 236400, China
Abstract:OBJECTIVE To explore the role of clinical pharmacists in anti-infective pharmacotherapy. METHODS The pharmaceutical practice of a patient with Chryseomonas luteola bloodstream infection and end stage renal disease was analyzed to explore how to make rational anti-infective schedule for infection patients with renal disease. RESULTS Clinical pharmacists actively participated in drug treatment, evaluated anti-infective treatment plans according to the guidelines, and gave recommendations for revision of reasonable anti-infective treatment plans based on drug susceptibility results and past patient history, and finally the infection was effectively controlled. CONCLUSION Infection can affect the quality of life seriously. Clinical pharmacists can help physicians to select rational antimicrobial drugs, usage and dosage, rational drug comnination, pay attention to the side effection, thus to make individual therapeutic schedule and ensure the rational use of antimicrobial drugs for infection patients with renal disease.
Keywords:Chryseomonas luteola  bloodstream infection  end stage renal disease  clinical pharmacists  pharmaceutical practice
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号